comprehensive -WSS

comprehensive

author：Wikipedia 2025-10-02 22:12:47 - browse：4552

Illustration of a red human heart with an EKG line in the middle. -- health coverage from STAT — Adobe

Just weeks after Novo Nordisk announced that its obesity drug Wegovy cut the risk of heart complications in a major trial, the company now has results from a different study showing the treatment can also benefit people with a common type of heart failure.

The results, published Friday in the New England Journal of Medicine, found that among people with obesity and heart failure with preserved ejection fraction, or HFpEF, those taking Wegovy experienced greater improvements in symptoms and physical function compared with those on placebo. The improvements were greater than what’s been seen in trials of some other HFpEF treatments.

Novo previously shared topline results in investor calls, but the new study contains the full findings, which are also being presented at the European Society of Cardiology conference this week.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Using force crossed my mind when examining a defiant young patient

WSS

Drug cartel violence flares in western Mexico after vigilante leader's killing

Using force crossed my mind when examining a defiant young patient

Drug cartel violence flares in western Mexico after vigilante leader's killing

5 ways to address the shortage of health care workers

Change Healthcare cyberattack shows risk of industry consolidation

Using force crossed my mind when examining a defiant young patient

Wikipedia

comprehensive

hotspot

Peter Hotez and the public health issue of online harassment

AstraZeneca lung cancer study comes in below expectations

Peter Hotez and the public health issue of online harassment

Childhood vaccination ad campaign launches in the U.K.

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Readout Newsletter: Beam, Prozac, "TechBio" and more

Novavax promises a turnaround & Lilly roils the obesity market

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Anesthesiologist group: stop taking Ozempic before surgery

Laying a path for careers in science

focus

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

Elisabeth Bik tackles the widespread issue of research misconduct

Readout Newsletter: Beam, Prozac, "TechBio" and more

Security flaws in third

What affirmative action's end means to a medical student

Cholera vaccine supplies dangerously low, outbreaks surging

leisure time

hotspot

entertainment

focus